Associate Professor of Medicine, Johns Hopkins University School of Medicine
Infectious Disease
Dr. Susan E. Dorman, MD
|
|
Give Review
Susan E. Dorman, MD works in the field of Infectious Disease. He graduated from Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine is ranked 8/29 in Research/PrimaryCare. Doctor Susan E. Dorman, MD is a published MD. He has 70 publications published. The most current publication "Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency." Susan Dorman is registered with Medicare and accepts Medicare payments.
Publications
- Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis.
- Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
- Quantification of Rifapentine, a Potent Anti-Tuberculosis Drug, from Dried Blood Spot Samples Using Liquid Chromatographic-Tandem Mass Spectrometric Analysis.
- Prospective Cross-Sectional Evaluation of the Small Membrane Filtration (SMF) Method for the Diagnosis of Pulmonary Tuberculosis.
- Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.
- Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States.
- A Summary of Meeting Proceedings on Addressing Variability around the Cut Point in Serial Interferon-γ Release Assay Testing.
- The Impact of Expanded Testing for Multidrug Resistant Tuberculosis Using Geontype MTBDRplus in South Africa: An Observational Cohort Study.
- Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey.
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium.
- Programmatic Impact of QuantiFERON-TB Gold In-Tube Implementation on Latent Tuberculosis Diagnosis and Treatment in a Public Health Clinic.
- Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Gold Miners in South Africa.
- Longitudinal Analysis of QuantiFERON-TB Gold In-Tube in Children with Adult Household Tuberculosis Contact in South Africa: A Prospective Cohort Study.
- Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.
- New diagnostic tests for tuberculosis: bench, bedside, and beyond.
- Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
- Coming-of-age of nucleic acid amplification tests for the diagnosis of tuberculosis.
- Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.
- Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis.
- Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
- Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.
- Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.
- Specimen dilution improves sensitivity of the amplified Mycobacterium tuberculosis direct test for smear microscopy-positive respiratory specimens.
- Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin.
- Lymphadenitis in an 18-month-old traveler to Mexico.
- Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care.
- Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
- From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.
- Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
- Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review.
- Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.
- A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states.
- Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits.
- Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection.
- Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.
- The rapid development of fluoroquinolone resistance in M. tuberculosis.
- Nocardia veterana as a pathogen in North American patients.
- Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens.
- Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.
- Nocardia infection in chronic granulomatous disease.
- Field evaluation of a rapid immunochromatographic test for tuberculosis.
- Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
- T-SPOT.TB responses during treatment of pulmonary tuberculosis.
- Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study.
- Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.
- The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
- Mycobacterium tuberculosis cell envelope lipids and the host immune response.
- Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses.
- Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency.
- Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for TB.
- Geographic differences in time to culture conversion in liquid media: tuberculosis trials consortium study 28. Culture conversion is delayed in Africa.
- QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact.
- Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas.
- Viral infections in interferon-gamma receptor deficiency.
- Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.
- Interferon-gamma and interleukin-12 pathway defects and human disease.
- Detection of intracellular phosphorylated STAT-1 by flow cytometry.
- Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon.
- Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
- 561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain.
- Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed.
- A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection.
- Mycobacterium tuberculosis in solid organ transplant recipients.
- Isolated intracranial infection with Mycobacterium avium complex.
- A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa.
- Nontuberculous mycobacteria in solid organ transplant recipients.
- Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
- Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda.
- Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa.
Schools
Duke University
Brigham and Women39s Hospital
National Institute Of Health
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Emblem Health
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Options PPO
Education
-
National Institutes of Health Clinical Center -
Brigham and Women's Hospital -
Duke University School of Medicine
Hospital
-
Johns Hopkins Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134169253 |
| Last Name Of The Provider | DORMAN |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
|
Dr. Anthony O. Edozien, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atiq U. Rahman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank M. Calia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meg C. Doherty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fiona Havers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dionissios Neofytos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Mayrer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eli N. Perencevich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shmuel Shoham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariam M. Khambaty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas C. Quinn, MD |
|
|
Dr. Larry W. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janaki C. Kuruppu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kerri A. Thom, MD
This Doctor is OpenDoctor Recommended.
|